bluebird bio Inc. (BLUE) Financial Statements (2025 and earlier)

Company Profile

Business Address 455 GRAND UNION BOULEVARD
SOMERVILLE, MA 02145
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2024
MRQ
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments221,755180,327303,1941,156,9041,106,4601,385,304
Cash and cash equivalents221,755113,006161,160317,705327,214402,579
Short-term investments  67,321142,034839,199779,246982,725
Restricted cash and investments9,2021,5022,2821,500  
Inventory, net of allowances, customer advances and progress billings22,919(7,500)(29,900)   
Inventory22,919(7,500)(29,900)   
Prepaid expense14,8008,37425,62837,47232,88819,762
Other undisclosed current assets13,00916,78535,31619,66112,82613,931
Total current assets:281,685199,488336,5201,215,5371,152,1741,418,997
Noncurrent Assets
Operating lease, right-of-use asset201,113281,99691,532184,019185,885
Property, plant and equipment 9,3629,706162,831151,176246,622
Long-term investments and receivables  1,41497,114122,891131,506506,123
Long-term investments  1,41497,114122,891131,506506,123
Intangible assets, net (including goodwill)16,08410,5145,64623,16927,45426,297
Goodwill5,6465,6465,64613,12813,12813,128
Intangible assets, net (excluding goodwill)10,4384,868 10,04114,32613,169
Restricted cash and investments 43,640     
Other noncurrent assets54,34352,12853,27772,80579,22944,805
Other undisclosed noncurrent assets 22,296     
Total noncurrent assets:337,476355,414257,275565,715575,250823,847
TOTAL ASSETS:619,161554,902593,7951,781,2521,727,4242,242,844
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities47,50647,87469,79599,600114,83017,831
Employee-related liabilities41,09555,80244,679 
Accounts payable18,49825,09225,88321,60242,99517,831
Accrued liabilities29,00822,7822,81722,19627,156 
Deferred revenue  1,5022,2822,3208,474
Debt84,705   20,175 
Restructuring reserve   4,673   
Customer refund liability 5,600     
Other liabilities      99,393
Contract with customer, liability18,602
Other undisclosed current liabilities62,30278,86176,243101,66880,10110,605
Total current liabilities:200,113128,237152,993203,588223,580146,431
Noncurrent Liabilities
Long-term debt and lease obligation37,732 66,432167,997170,812 
Finance lease, liability37,732    
Liabilities, other than long-term debt186,779230,3229333,03020,20524,675
Deferred revenue    25,7629,791
Contract with customer, liability16,338
Other liabilities9292937,2682,4373,107
Operating lease, liability186,687230,23066,432167,997170,812
Business combination, contingent consideration, liability     7,9775,230
Other undisclosed noncurrent liabilities    21,58127,834186,668
Total noncurrent liabilities:224,511230,32266,525222,608218,851211,343
Total liabilities:424,624358,559219,518426,196442,431357,774
Equity
Equity, attributable to parent194,537196,343374,2771,355,0561,284,9931,885,070
Common stock1,905830711665554547
Additional paid in capital4,454,7564,186,0864,096,4024,260,4433,568,1843,386,958
Accumulated other comprehensive loss(1,796)(4,070)(2,911)(5,505)(1,893)(3,627)
Accumulated deficit(4,260,328)(3,986,503)(3,719,925)(2,900,547)(2,281,852)(1,498,808)
Total equity:194,537196,343374,2771,355,0561,284,9931,885,070
TOTAL LIABILITIES AND EQUITY:619,161554,902593,7951,781,2521,727,4242,242,844

Income Statement (P&L) ($ in thousands)

9/30/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Revenues29,4973,5973,662250,73444,67454,579
Sublease income41,165    
Loss on disposition of assets for financial service operations (100)(3,100)    
Cost of revenue(33,527)(112,077)(38,857)(5,396)(5,725)(885)
Cost of goods and services sold  (7,519)(29,924)(5,396)(2,978)(885)
Gross profit:(4,030)(108,480)(35,195)245,33838,94953,694
Operating expenses(240,232)(280,612)(555,716)(874,852)(853,775)(626,602)
Other undisclosed operating income  102,000 6,468 885
Operating loss:(244,262)(287,092)(590,911)(623,046)(814,826)(572,023)
Nonoperating income (expense)48,57619,59927,652(6,502)(10,088)1,961
Investment income, nonoperating9,869     
Other nonoperating income (expense)38,70719,59927,652(6,502)(10,088)1,961
Interest and debt expense(16,353)     
Other undisclosed loss from continuing operations before equity method investments, income taxes      
Loss from continuing operations before equity method investments, income taxes:(212,039)(267,493)(563,259)(629,548)(824,914)(570,062)
Other undisclosed income (loss) from continuing operations before income taxes 1,03287911,53934,76114,624
Loss from continuing operations before income taxes:(212,039)(266,461)(562,380)(618,009)(790,153)(555,438)
Income tax expense (benefit)126(117)(258)(686)545(187)
Loss from continuing operations:(211,913)(266,578)(562,638)(618,695)(789,608)(555,625)
Loss before gain (loss) on sale of properties:(562,638)(618,695)(789,608)(555,625)
Net loss:(211,913)(266,578)(562,638)(618,695)(789,608)(555,625)
Other undisclosed net loss attributable to parent   (256,740)   
Net loss available to common stockholders, diluted:(211,913)(266,578)(819,378)(618,695)(789,608)(555,625)

Comprehensive Income ($ in thousands)

9/30/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Net loss:(211,913)(266,578)(562,638)(618,695)(789,608)(555,625)
Other comprehensive income (loss) 2,274(1,159)2,364(3,612)1,734578
Other undisclosed comprehensive income      
Comprehensive loss:(209,639)(267,737)(560,274)(622,307)(787,874)(555,047)
Other undisclosed comprehensive loss, net of tax, attributable to parent  (256,740)   
Comprehensive loss, net of tax, attributable to parent:(209,639)(267,737)(817,014)(622,307)(787,874)(555,047)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: